1. Home
  2. UA vs IDYA Comparison

UA vs IDYA Comparison

Compare UA & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Under Armour Inc. Class C

UA

Under Armour Inc. Class C

HOLD

Current Price

$6.11

Market Cap

3.4B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.21

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UA
IDYA
Founded
1996
2015
Country
United States
United States
Employees
14400
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
UA
IDYA
Price
$6.11
$32.21
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$52.86
AVG Volume (30 Days)
2.3M
1.5M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.57
$201.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$3.95
$16.81
52 Week High
$7.91
$39.28

Technical Indicators

Market Signals
Indicator
UA
IDYA
Relative Strength Index (RSI) 52.24 50.17
Support Level $5.86 $29.29
Resistance Level $6.44 $34.76
Average True Range (ATR) 0.25 2.09
MACD 0.08 0.10
Stochastic Oscillator 82.32 27.53

Price Performance

Historical Comparison
UA
IDYA

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: